JPRN-UMIN000007142已完成2 期
Phase II study of TS-1 and CPT-11 combination chemotherapy in patients with advanced/recurrent colorectal cancer. - Phase II study of TS-1 and CPT-11 combination chemotherapy in patients with advanced/recurrent colorectal cancer.
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group0 个研究点目标入组 55 人开始时间: 2012年1月26日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Interstitial pneumoni, fibroid lung 2) Massive pleural or abdominal effusion 3) Patients with active synchronous or metachronous malignancy other than carcinoma in situ 4) Infection, intestinal paralysis / enterostasis 5) Watery stools or diarrhea 6) Uncontrolled diabetes mellitus 7) Severe complications 8) Metastasis to CNS 9) Pregnant or lactating woman 10) History of the severe hypersensitivity 11) Systemic administration of corticosteroids 12) Other patients who are unfit for the study as determined by the attending physician.
研究者
相似试验
已完成
不适用
Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancerPreviously untreated stageIIIB/IV NSCLCJPRN-C000000415West Japan Oncology Group55
招募中
2 期
Phase II study of TS-1+CPT-11+BV followed by TS-1+L-OHP+BV in unresectable advanced colorectal cancer with RAS mutatioColorectal cancerJPRN-UMIN000014892iigata Colorectal Cancer Study Group50
未知
1 期
Phase1study of a combination of CPT-11 and TS-1 and bevacizumab in patients with metastatic colon cancermetastatic colorectal cancerJPRN-UMIN000001219Department of Surgery, Suita Municipal Hospital24
已完成
2 期
Phase II study of a combination of CPT-11 and S-1 and Panitumumab in patients with KRAS wild-type metastatic colon cancer.KRAS wild-type metastatic colon cancer.JPRN-UMIN000005368iigata Colorectal cancer Chemotherapy Study Group (NCCSG)25
已完成
2 期
Phase II study of a combination of CPT-11 and S-1 and bevacizumab in patients with metastatic colon cancer.metastatic colorectal cancerJPRN-UMIN000001631iigata Colorectal cancer Chemotherapy Study Group (NCCSG)35